US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Regnum Corp.

0.0000

0.0000

Volume:- -

Turnover:- -

Market Cap:22.95

PE:0.00

High:0.0000

Open:0.0000

Low:0.0000

Close:0.0000

52wk High:0.0000

52wk Low:0.0000

Shares:22.95M

Float Shares:270.00K

Volume Ratio:0.34

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0302

EPS(LYR):-0.0340

ROE:669.54%

ROA:-42.02%

PB:-0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Regnum Corp.

Exchange:

EXPERT

Establishment Date:

2016

Employees:

2

Office Location:

600 Third Avenue,19th Floor,New York,New York,United States

Website:

http://www.regnumcorp.com

Zip Code:

10016

Phone:

Fax:

- -

Introduction:

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RGMP/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RGMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGMP\",,,,,undefined,":{"symbol":"RGMP","market":"US","secType":"STK","nameCN":"Regnum Corp.","latestPrice":0.000001,"timestamp":1781812800000,"preClose":0.000001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":269999,"shares":22950000,"eps":-0.030226,"marketStatus":"Market Closed","change":0,"latestTime":"06-18 16:00:00 EDT Delay","open":0.000001,"high":0.000001,"low":0.000001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.030226,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.000001,"volumeRatio":0.33641338514444846},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGMP\",,,,,undefined,":{"symbol":"RGMP","floatShares":269999,"roa":"-42.02%","roe":"669.54%","lyrEps":-0.034025,"volumeRatio":0.33641338514444846,"shares":22950000,"dividePrice":0,"high":0.000001,"amplitude":0,"preClose":0.000001,"low":0.000001,"week52Low":0.000001,"pbRate":"-0.00","week52High":0.000001,"institutionHeld":0,"latestPrice":0.000001,"eps":-0.030226,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.030226,"open":0.000001,"prevYearClose":0.000001,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGMP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RGMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":546758726,"yearFounded":2016,"employeeNum":2,"address":"600 Third Avenue,19th Floor,New York,New York,United States","zipCode":"10016","officePhone":"877 313 2232","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.regnumcorp.com","stockEarnings":[{"period":"1week","weight":0.0714},{"period":"1month","weight":1.5},{"period":"3month","weight":0.5},{"period":"6month","weight":1},{"period":"ytd","weight":1}],"description":"Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.","exchange":"EXPERT","name":"Regnum Corp.","nameEN":"Regnum Corp."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RGMP\",market:\"US\",,,undefined,":null}}